Actively Recruiting
Pharmacogenomics-Supported Psychotropic Prescribing Trial
Led by University of Manitoba · Updated on 2025-09-08
200
Participants Needed
2
Research Sites
287 weeks
Total Duration
On this page
Sponsors
U
University of Manitoba
Lead Sponsor
U
University of Calgary
Collaborating Sponsor
AI-Summary
What this Trial Is About
Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.
CONDITIONS
Official Title
Pharmacogenomics-Supported Psychotropic Prescribing Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18 years or older
- The initiation, change, dose adjustment, or augmentation of psychotropic medication(s) is indicated
- The treating clinician thinks PGx testing can benefit and refers the patient to the study
You will not qualify if you...
- Unwillingness to donate saliva samples for genetic analysis
- History of liver or bone marrow (hematopoietic cell) transplantation
- PGx testing results are already available
- No personal health identification number (PHIN) is available
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Shared Health Facilities
Winnipeg, Manitoba, Canada, R3C 3H8
Not Yet Recruiting
2
University of Manitoba College of Pharmacy
Winnipeg, Manitoba, Canada, R3E 0T5
Actively Recruiting
Research Team
A
Abdullah Al Maruf, BPharm, MPharm, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here